Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 1:39 AM
NCT ID:
NCT00409994
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven rectum cancer
* UICC TNM I-III
* WHO performance status 0-2
* Less than 10% weight loss the last 6 months
* No recent (\< 3 months) severe cardiac disease
* Normal serum bilirubin and serum creatinin
Exclusion Criteria:
* Concurrent chemotherapy with radiation
* History of prior pelvis radiotherapy
* Recent (\<3 months) myocardial infarction
* Uncontrolled infectious disease
* Concurrent medication known as inhibitors of CYP3A4 susceptible to increase Rapamycin blood concentrations
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00409994
Study Brief:
Protocol Section:
NCT00409994